Whether it’s for managing type 2 diabetes or preventing the disease, the supplement berberine has some potential. For one thing, it may lower your A1C. Read more about the science-backed pros ...

TOPLINE: Berberine ursodeoxycholate (HTD1801) showed potential as a treatment option for patients with type 2 diabetes (T2D), with significant reductions in A1c and fasting plasma glucose levels.

The 14-site trial was conducted in China between March 2022 and January 2023 and enrolled 113 participants with type 2 diabetes. Average age was 54.3 years and 63.7% were male.

A clinical trial to test the effectiveness of a new, plant-based oral drug to treat type 2 diabetes has produced some promising results. The drug significantly improved blood glucose control and ...

HighTide Therapeutics Announces Publication of Phase 2 Study of Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes Mellitus in JAMA Network Open ACN Newswire - Mon Mar 3, 9:26PM CST ...

Ozempic, a prescription-only type 2 diabetes drug with the active ingredient semagulatide, has become popular thanks to its ability to aid in weight loss.With increased popularity and demand ...

Why understanding the differences between Type 1 and Type 2 diabetes is essential for better health management and effective treatment options.

Gastric bypass is often the best type of bariatric surgery for type 2 diabetes, but other options like sleeve gastrectomy or duodenal switch may work better, depending on your health needs ...

Type 2 diabetes accounts for approximately 90-95% of diabetes cases globally. Unlike the autoimmune destruction seen in type 1, type 2 develops when cells throughout the body become increasingly ...

Jim Cox had heard of people with Type 2 diabetes who were unable to get Ozempic because the drug was being used off-label for weight loss. He just didn't think the shortage would affect him. He ...

The 14-site trial was conducted in China between March 2022 and January 2023 and enrolled 113 participants with type 2 diabetes. Average age was 54.3 years and 63.7% were male.